Caius Radu, Christine Mona, Amar Kishan, Beth Glenn, Mina Sedrak, William Lowry named program leaders at UCLA Health Jonsson CCC

Cytokine-armored CAR T-cell therapy helps eliminate aggressive brain tumors in UCLA preclinical study

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a cytokine-armored CAR T-cell therapy that helps the immune system better attack aggressive brain tumors in mice while reducing dangerous side effects that have long limited immune-based treatments for glioblastoma, one of the deadliest and most treatment-resistant brain cancers.

May 29, 2026

Vol.52 No.21

Cancer Policy

FDA’s acting drug chief, acting vaccines chief, and chief of staff ousted in the wake of Makary departure

In further major FDA shake-ups, three top regulators left the agency on May 15, just days after the resignation of Commissioner Marty Makary.

May 22, 2026

Vol.52 No.20

By Claire Marie Porter

In Brief

Charles Rudin named cancer center director at MSK

Charles Rudin was appointed director of Memorial Sloan Kettering Cancer Center, effective June 1.

May 22, 2026

Vol.52 No.20

In Brief

Albert Koong named chief scientific officer at MD Anderson

Albert Koong was appointed chief scientific officer at the University of Texas MD Anderson Cancer Center effective June 1.

May 22, 2026

Vol.52 No.20

Cancer Policy

DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions

The U.S. Department of Justice issued a letter alleging that Yale Medical School of violating anti-discrimination laws and instititing policies that disadvantaged white and Asian applicants while favoring Black and Hispanic applicants. The DOJ investigation, which was launched a year ago, reviewed the school’s admission policies for the class of 2023, 2024, and 2025, the...

Nhan L. Tran to join TGen faculty as distinguished professor

Nhan L. Tran was named distinguished professor, vice president of Cancer Discovery and Translation, co-director of the Immunology and Microbiome Division, and scientific director of the Microbiome and Immuno-Oncology program at the Translational Genomics Research Institute, which is part of City of Hope.

May 15, 2026

Vol.52 No.19

Caius Radu, Christine Mona, Amar Kishan, Beth Glenn, Mina Sedrak, William Lowry named program leaders at UCLA Health Jonsson CCC

YOU MAY BE INTERESTED IN

Cytokine-armored CAR T-cell therapy helps eliminate aggressive brain tumors in UCLA preclinical study

FDA’s acting drug chief, acting vaccines chief, and chief of staff ousted in the wake of Makary departure

Charles Rudin named cancer center director at MSK

Albert Koong named chief scientific officer at MD Anderson

DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions

Nhan L. Tran to join TGen faculty as distinguished professor

Renew today!

Subscriber content

Never miss an issue!

Login